The first Sunday in June is National Cancer Survivors Day — an annual moment to recognise the growing community of women living well after a gynaecological cancer diagnosis. Below are five lessons drawn from long-term survivors I have followed in my practice over the past decade.
The short answer: many women live for years after ovarian cancer (अंडाशय का कैंसर, andashay ka cancer). The lessons below are Dr. Nishtha’s own observations from women she has followed, written for National Cancer Survivors Day in June 2026 — they are not the results of a formal study. Every woman’s cancer type, stage and treatment are different, so these lessons are not a promise of any particular outcome.
On this page
- Lesson 1: Surgical completeness is non-negotiable
- Lesson 2: Maintenance therapy quietly changes outcomes
- Lesson 3: BRCA testing is for living, not just diagnosis
- Lesson 4: Surveillance fatigue is real — and dangerous
- Lesson 5: Survivorship is a relationship, not a date
Lesson 1: Surgical completeness is non-negotiable
The single strongest predictor of long-term ovarian cancer survival is achieving complete cytoreduction (no visible residual disease) at primary surgery. Survivors who later thrive almost always had CC-0 or CC-1 resection by a fellowship-trained surgical team. Volume of cases matters — both the surgeon’s and the centre’s.
Lesson 2: Maintenance therapy quietly changes outcomes
The introduction of PARP inhibitor maintenance (olaparib, niraparib, rucaparib) has changed survival profiles for BRCA-mutated and HRD-positive ovarian cancer. Many long-term survivors started maintenance therapy after first-line completion and have maintained remission for years. Not every woman needs maintenance treatment; the benefit is greatest when the cancer is BRCA- or HRD-positive, and your team decides whether it suits you.
Lesson 3: BRCA testing is for living, not just diagnosis
BRCA1/2 testing is usually recommended as part of ovarian cancer diagnosis and treatment, but it is not just about treatment decisions. It can also show whether your daughter, sister or niece may carry the same risk. Several long-term survivors I follow have used their result to help relatives get tested and plan screening or risk-reducing options with their own doctors.
Lesson 4: Surveillance fatigue is real — and dangerous
Around year 3–4 of surveillance, energy and attention dip. Patients miss CA-125 tests. They skip 6-monthly reviews. The survivors who do best are the ones who treat surveillance like a 5-year contract, not an optional habit.
Lesson 5: Survivorship is a relationship, not a date
The 5-year mark is a statistical milestone, not a finish line. Long-term survivors maintain a working relationship with their oncologist for symptoms, late effects, and second opinions on adjacent decisions (hormone replacement, bone health, sexual function). Survivorship care is medicine; not just memory.
What to do
If you are a survivor approaching the 5-year mark, or a family member of a survivor, book a survivorship review with Dr. Nishtha. WhatsApp +91 76988 00333.
External: National Cancer Institute Ovarian Cancer Guide. See also our recurrent disease treatment page.
FAQs
What counts as a 'long-term' ovarian cancer survivor?
Generally, 5+ years from diagnosis without active disease. For advanced-stage diagnoses, even 3-year disease-free intervals are clinically meaningful and worth marking.
Do all ovarian cancer patients need lifelong follow-up?
Most women stay in follow-up for many years, but visits become less frequent over time. Check-ups are closest together in the first few years after treatment, become less frequent up to about year 5, and are then usually yearly. Your own schedule depends on your stage and treatment. Late recurrences can happen, so tell your team about any new symptoms between visits.
Is PARP maintenance available in India?
PARP inhibitors such as olaparib and niraparib are used in India, but which medicines are approved and available can change, so the team confirms the current options for you. Cost varies; insurance coverage is improving but pre-authorisation is required for most policies.
What is a 'survivorship clinic'?
A combined service that addresses cancer follow-up plus the long-term effects of treatment — fatigue, bone health, sexual function, second-cancer screening. Increasingly important as more women live decades after diagnosis.
Can my family members be tested for BRCA too?
Yes, if a BRCA change is found. Usually the woman who has had cancer is tested first. If she is BRCA-positive, close relatives are offered testing for the same change (called cascade testing), with genetic counselling to explain what a result means for them.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. For consultations: WhatsApp +91 76988 00333.